Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Raslan, Omar
NCT05326464: Tofacitinib in Recurrent GBM Patients	Recruiting	3	20	US	Tofacitinib 10mg	University of Texas Southwestern Medical Center, Pfizer	Glioblastoma	06/25	06/26
ReSPECT-GBM, NCT01906385: Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)	Recruiting	1/2	55	US	Rhenium Liposome Treatment, Rhenium-186 NanoLiposome	Plus Therapeutics, National Cancer Institute (NCI)	Glioma	01/25	01/25
ReSPECT-LM, NCT05034497: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases	Recruiting	1	18	US	186RNL, Rhenium-186 NanoLiposome	Plus Therapeutics	Leptomeningeal Metastasis	12/25	06/26